Tumour Cell-Based Vaccine for Mantle Cell Lymphoma
A phase I/II clinical trial by researchers at Stanford University suggests that vaccines prepared from a patient's own tumour cells may prevent the incurable blood cancer mantle cell lymphoma (MCL)...